Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX - Université de Reims Champagne-Ardenne Access content directly
Journal Articles Oncotarget Year : 2015

Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX

Abstract

During tumor invasion, tumor cells degrade the extracellular matrix. Basement membrane degradation is responsible for the production of peptides with anti-tumor properties. Type XIX collagen is associated with basement membranes in vascular, neuronal, mesenchymal and epithelial tissues. Previously, we demonstrated that the non-collagenous NC1, C-terminal, domain of collagen XIX [NC1(XIX)] inhibits the migration capacities of tumor cells and exerts a strong inhibition of tumor growth. Here, we demonstrate that plasmin, one of the most important enzyme involved in tumor invasion, was able to release a fragment of NC1(XIX), which retained the anti-tumor activity. Molecular modeling studies showed that NC1(XIX) and the antitumor fragment released by plasmin (F4) adopted locally the same type I β-turn conformation. This suggests that the anti-tumor effect is conformation-dependent. This study demonstrates that collagen XIX is a novel proteolytic substrate for plasmin. Such release may constitute a defense of the organism against tumor invasion.
Fichier principal
Vignette du fichier
oncotarget_6_6.pdf (4.07 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03541824 , version 1 (25-01-2022)

Licence

Attribution

Identifiers

Cite

Jean-Baptiste Oudart, Sylvie Brassart-Pasco, Alexia Vautrin, Christèle Sellier, Carine Machado, et al.. Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX. Oncotarget, 2015, 6 (6), pp.3656-3668. ⟨10.18632/oncotarget.2849⟩. ⟨hal-03541824⟩
40 View
18 Download

Altmetric

Share

Gmail Facebook X LinkedIn More